Treatment pattern and outcomes in patients with uncommon or compound EGFR mutations in India: CRSF 2020-03 study

MLA

Manuprasad Avaronnan, et al. “Treatment Pattern and Outcomes in Patients with Uncommon or Compound EGFR Mutations in India: CRSF 2020-03 Study.” Journal of Clinical Oncology, vol. 40, June 2022, p. e21034. EBSCOhost, https://doi.org/10.1200/jco.2022.40.16_suppl.e21034.

APA

Manuprasad Avaronnan, Rushabh Kothari, Avinash Talele, Vikas Talreja, Gautam Goyal, Nirmal Vivek Raut, & Ashay Karpe. (2022). Treatment pattern and outcomes in patients with uncommon or compound EGFR mutations in India: CRSF 2020-03 study. Journal of Clinical Oncology, 40, e21034. https://doi.org/10.1200/jco.2022.40.16_suppl.e21034

Chicago

Manuprasad Avaronnan, Rushabh Kothari, Avinash Talele, Vikas Talreja, Gautam Goyal, Nirmal Vivek Raut, and Ashay Karpe. 2022. “Treatment Pattern and Outcomes in Patients with Uncommon or Compound EGFR Mutations in India: CRSF 2020-03 Study.” Journal of Clinical Oncology 40 (June): e21034. doi:10.1200/jco.2022.40.16_suppl.e21034.